“Providing the vaccine to only a small number of relatively well-off South Africans serves no real purpose”, writes Yamkela Makupula, CEO of Diaz Reus Africa.
“Providing the vaccine to only a small number of relatively well-off South Africans serves no real purpose”, writes Yamkela Makupula, CEO of Diaz Reus Africa.